To determine the intensity of DNA damage response after cisplatin treatment in REV3L overexpression or suppression cervical cancer cell lines, we detected γ-H2AX (pS139) foci formation using immunofluorescence. The gene discussed is H2AX; the disease is cervical carcinoma.